Insider Cluster (2 insiders) ·Filed Jul 2, 2026

SION

Sionna Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $10.5M total
Actionable Insight • Neutral

Monitor for any lockup expiration or 10b5-1 plan disclosure that would explain the coordinated sale. Given the historical pattern of bearish calls on SION being wrong, this cluster is unlikely to signal material downside. Watch for any insider buying in the coming weeks to gauge conviction.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+60d
SION ▼ -88.11% at T+60d
NEUTRAL call ✗ call lost -88.11% · α vs SPY -91.12% · entry $43.99 → $5.23
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
+2.16%
call +2.16% · α +1.23%
$44.94
settled 3mo ago
T+20d
+6.34%
call +6.34% · α +6.76%
$46.78
settled 2mo ago
T+60d
-88.11%
call -88.11% · α -91.12%
$5.23
settled 7d ago

Price Chart

Loading chart...

Executive Summary

Two Sionna Therapeutics directors (OrbiMed Advisors LLC and Peter A. Thompson) each sold 115,844 shares at $45.50 on June 30, 2026, totaling $10.54M (0.55% of market cap). The identical timing and amounts suggest a coordinated exit, possibly related to a lockup expiration or planned selling program, rather than opportunistic insider selling. Historical bearish calls on SION have been consistently wrong, reducing the signal value of this cluster.

Key Financial Metrics

Direction
selling
Total Value
$10.5M
Insiders
2

Key Facts

  • Two directors sold identical amounts (115,844 shares each) on the same day at $45.50/share.
  • Total insider selling of $10.54M represents 0.55% of SION's $1.9B market cap.
  • Neither C-suite executive participated in the selling; all sellers are directors.
  • Recent bearish calls on SION (4 of 4 in the past 3 months) have been incorrect, with the stock rising after each.

Financial Impact

Two directors sold $10.54M combined, representing 0.55% of market cap.

insider selling

Risk Factors

  • Potential insider pessimism if selling is not part of a pre-arranged plan.
  • Further selling by remaining insiders could pressure the stock.
  • Historical bearish calls on SION have been incorrect, so this cluster may be a false signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SION-1783060148323
16 reports for SION
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+60▲ +88.41%Jul 7, 2026
Filters
Rows
Reports for SION — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
BEARISH ★ 7/10
$4.50 $7.30▼ −62.22%▼ −63.14%$5.04 (−12.00%)
Aug 6, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$49.61 $6.75▼ −86.39%▼ −86.99%$5.04 (−89.84%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$45.29 $51.04▲ +12.70%▲ +10.27%$5.04 (−88.87%)
Jul 9, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$45.29 $51.04▼ −12.70%▼ −10.27%$5.04 (+88.87%)
Jul 7, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$44.00 $47.34▼ −7.59%▼ −4.32%$5.04 (+88.55%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$43.99 $46.78▲ +6.34%▲ +6.76%$5.04 (−88.54%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$36.05 $44.94▲ +24.66%▲ +22.77%$5.04 (−86.02%)
May 30, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.90 $43.99▲ +7.55%▲ +8.85%$5.04 (−87.68%)
May 29, 2026
17w ago
144
BEARISH ★ 6/10
$40.90 $43.99▼ −7.55%▼ −8.85%$5.04 (+87.68%)
May 12, 2026
20w ago
8-K
NEUTRAL ★ 5/10
$40.94 $34.03▼ −16.88%▼ −15.15%$5.04 (−87.69%)
Showing 10 of 16

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026